Loading organizations...
Key people at dii - an Economist Intelligence Unit - Healthcare business.
dii - an Economist Intelligence Unit - Healthcare business was founded in 2006 by Martin Pfister (Founder, Partner).
Based in Leipzig, Germany, dii - an Economist Intelligence Unit - Healthcare business provides specialized market intelligence and strategic advisory services for the global healthcare industry. The firm assists corporate clients operating across the laboratory diagnostics, medical device, pharmaceutical, and biotechnology sectors with comprehensive market assessments and competitive benchmarking. Its core consulting offerings include developing go-to-market strategies and delivering actionable customer insights to help healthcare enterprises implement sustainable commercial growth initiatives. The organization was officially acquired by the Economist Intelligence Unit in October 2018, integrating its specialized medical consulting operations into the broader corporate intelligence portfolio. The healthcare division currently operates under the executive leadership of EIU Managing Director Leon Calvert, who was appointed to the position in April 2025. The original founding year and the identities of the initial founders remain undisclosed in public records.
Key people at dii - an Economist Intelligence Unit - Healthcare business.
dii - an Economist Intelligence Unit - Healthcare business was founded in 2006 by Martin Pfister (Founder, Partner).
data information intelligence GmbH (dii) is a specialized market research and consulting firm focused on healthcare, particularly diagnostics, medical devices, and imaging. Operating as "an Economist Intelligence Unit" company, it compiles market data from diverse sources, transforms it into actionable intelligence, and supports strategic decisions like market entry, product launches, and growth assessments through credible models, penetration analysis, and customized research.[1][2]
Founded in 2006 and based in Leipzig, Germany, dii serves healthcare companies by minimizing risks and identifying opportunities in high-value markets via proprietary or multi-client studies. With around 7 employees and approximately $2 million in annual revenue, it emphasizes business intelligence tools to evaluate user needs, product viability, and commercial potential.[1]
dii was established in 2006 in Leipzig, Saxony, Germany, as data information intelligence GmbH, addressing the need for specialized healthcare market intelligence.[1] While specific founders are not detailed in available records, the firm quickly positioned itself as a full-service marketing consultant, leveraging varied data sources to focus on diagnostics, medical devices, and imaging sectors.[1][2]
A pivotal moment came in 2018 when Luther law firm advised on its sale, highlighting dii's role in supporting strategic decisions for medical product companies, which likely expanded its visibility and client base.[2] Its branding as "an Economist Intelligence Unit" ties it to the EIU's global research ecosystem, though it operates as a distinct GmbH entity.[1][4]
dii stands out in the healthcare market research space through:
These elements provide clients with precise, actionable outputs beyond generic research.[1]
dii rides the wave of data-driven healthcare decision-making, where rising demand for diagnostics and medical devices intersects with needs for predictive analytics amid regulatory pressures and market expansions.[1][3] Its timing aligns with global healthcare trends like stricter regulations, pricing challenges, and tech integration (e.g., AI in budgeting), as noted in EIU reports forecasting real-terms spending growth post-inflation disruptions.[3]
Market forces favoring dii include healthcare's shift toward evidence-based strategies, with firms needing tools to navigate strikes, sustainability concerns, and innovation in imaging/products.[2][3] By influencing ecosystems through intelligence that supports first-to-market launches and regional entries (e.g., Europe-focused from its German base), dii contributes to efficient resource allocation in a sector projected to grow, indirectly bolstering startups and incumbents in medtech.[1]
dii is poised for steady growth by capitalizing on EIU synergies and healthcare's data analytics boom, potentially expanding multi-client studies into emerging markets like Asia-Pacific life sciences, echoing EIU acquisitions like Clearstate.[4] Trends such as AI-driven forecasting and climate-impacted health spending will shape its trajectory, demanding agile models for volatile environments.[3]
Its influence may evolve toward deeper tech integration, like predictive tools for sustainability, solidifying its niche while riding global spending upticks—echoing its core strength in transforming data into commercial wins.[1][3]
